Literature DB >> 187917

Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.

H W Doerr, G Gross, H Schmitz.   

Abstract

Forty-two patients with herpes simplex virus infections were tested for neutralizing serum IgM antibodies. A technique in which serum antibody fluorescein staining was combined with sucrose gradient centrifugation facilitated the isolation of the serum IgM fraction for the use in neutralization tests. In nearly all cases with primary infection, especially those presenting heavy clinical signs (encephalitis/meningitis) the IgM tests were positive. In one case we could detect the IgM antibodies for 11 weeks after the onset of the illness, in another case in cerebrospinal fluid samples for 6 weeks. In localized herpes infections, which were mostly due to reactivations, serum IgM antibodies could only rarely be demonstrated. Among the serologic tests used in this study (NT, CFT, IFT, ACIFT), only the CFT beside the NT (with certain reservations) can be applied for subtyping HSV serum antibodies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187917     DOI: 10.1007/bf02120996

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  15 in total

1.  Simple detection of fluorescent stained IgM in sucrose gradients: demonstration of virus-specific IgM.

Authors:  H Schmitz; C M Krainick-Rechert
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

2.  Typing of Herpesvirus simplex hominis 1 and 2 by indirect immunofluorescence.

Authors:  H W Doerr; M Rau; H Schmitz
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

3.  Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence.

Authors:  H Schmitz; R Haas
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  [Diagnosis of acute virus infection using the IgM-fraction of patients sera (author's transl)].

Authors:  K E Schneweis; M H Wolff; G Marklein; G Stifter
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1974-08

5.  Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.

Authors:  M L Martin; E L Palmer; R E Kissling
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

6.  Antibodies to Herpesvirus hominis types 1 and 2 in the rabbit.

Authors:  A J Nahmias; W R Dowdle; J H Kramer; C F Luce; S C Mansour
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

7.  [Coxsackie B virus neutralising antibodies in myocarditis and pleurodynia].

Authors:  H W Doerr
Journal:  Dtsch Med Wochenschr       Date:  1973-07-20       Impact factor: 0.628

8.  [Formation of antibody to nucleocapsid and envelope of Herpes simplex virus hominis].

Authors:  H W Doerr; H Schmitz; E E Petersen
Journal:  Zentralbl Bakteriol Orig A       Date:  1974

9.  Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans.

Authors:  N J Schmidt; B Forghani; E H Lennette
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

10.  Reactivity of envelope, capsid, and soluble antigens of Herpesvirus hominis types 1 and 2 in the indirect hemagglutination test.

Authors:  A F Back; N J Schmidt
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  5 in total

1.  Unusual course of herpes simplex virus encephalitis after acyclovir therapy.

Authors:  W Preiser; B Weber; G Klös; P A Fischer; H W Doerr
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

2.  Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

Authors:  N E Cremer; V L Devlin; J L Riggs; S J Hagens
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

3.  Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.

Authors:  H W Doerr; M Rentschler; G Scheifler
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

4.  [The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)].

Authors:  R Jarisch; I Sandor; C Cerni
Journal:  Arch Dermatol Res       Date:  1979-05-29       Impact factor: 3.017

5.  Influenza virus-specific neutralizing IgM antibodies persist for a lifetime.

Authors:  Ioanna Skountzou; Lakshmipriyadarshini Satyabhama; Anastasia Stavropoulou; Zuhha Ashraf; E Stein Esser; Elena Vassilieva; Dimitrios Koutsonanos; Richard Compans; Joshy Jacob
Journal:  Clin Vaccine Immunol       Date:  2014-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.